191 related articles for article (PubMed ID: 32445833)
1. Intravenous drug use history is not associated with poorer outcomes after arteriovenous access creation.
Levin SR; Farber A; Arinze N; Talutis SD; Cheng TW; Malas MB; Tan TW; Rybin D; Siracuse JJ
J Vasc Surg; 2021 Jan; 73(1):291-300.e7. PubMed ID: 32445833
[TBL] [Abstract][Full Text] [Related]
2. Patients with human immunodeficiency virus infection do not have inferior outcomes after dialysis access creation.
Dicken QG; Cheng TW; Farber A; Levin SR; Jones DW; Malas MB; Tan TW; Rybin D; Siracuse JJ
J Vasc Surg; 2020 Dec; 72(6):2113-2119. PubMed ID: 32276018
[TBL] [Abstract][Full Text] [Related]
3. Higher body mass index is associated with reinterventions and lower maturation rates after upper extremity arteriovenous access creation.
Raulli SJ; Sather K; Dicken QG; Farber A; Kalish JA; Eslami MH; Zhang Y; Cheng TW; Levin SR; Siracuse JJ
J Vasc Surg; 2021 Mar; 73(3):1007-1015. PubMed ID: 32442609
[TBL] [Abstract][Full Text] [Related]
4. Patients with lower extremity dialysis access have poor primary patency and survival.
Pike SL; Farber A; Arinze N; Levin S; Cheng TW; Jones DW; Tan TW; Malas M; Rybin D; Siracuse JJ
J Vasc Surg; 2019 Dec; 70(6):1913-1918. PubMed ID: 31147128
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness of open thrombectomy for thrombosed autogenous arteriovenous fistulas and grafts.
Ghaffarian AA; Al-Dulaimi R; Kraiss LW; Sarfati M; Griffin CL; Smith BK; Donald G; Brooke BS
J Vasc Surg; 2018 Jul; 68(1):189-196. PubMed ID: 29526376
[TBL] [Abstract][Full Text] [Related]
6. Octogenarians and Nonoctogenarians Have Similar Outcomes after Upper Extremity Hemodialysis Access Creation.
Dicken Q; Sather K; Farber A; Mendez L; Castro V; Zhang Y; Levin SR; Talutis SD; Raulli SJ; Siracuse JJ
Ann Vasc Surg; 2020 Nov; 69():34-42. PubMed ID: 32599116
[TBL] [Abstract][Full Text] [Related]
7. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
[TBL] [Abstract][Full Text] [Related]
8. Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access.
Smeds MR; Cheng TW; King E; Williams M; Farber A; Chitalia VC; Siracuse JJ;
J Vasc Surg; 2024 Apr; 79(4):925-930. PubMed ID: 38237702
[TBL] [Abstract][Full Text] [Related]
9. Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access.
Roberts L; Farber A; Jones DW; Woo K; Eslami MH; Simons J; Malas M; Tan TW; Rybin D; Siracuse JJ
J Vasc Surg; 2019 May; 69(5):1552-1558. PubMed ID: 30583896
[TBL] [Abstract][Full Text] [Related]
10. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.
Arhuidese IJ; Orandi BJ; Nejim B; Malas M
J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with a tunneled dialysis catheter in place at initial arteriovenous access creation.
Ryan TJ; Farber A; Cheng TW; Raulli SJ; Sather K; Dicken QG; Levin SR; Zhang Y; Siracuse JJ
J Vasc Surg; 2021 May; 73(5):1771-1777. PubMed ID: 33068763
[TBL] [Abstract][Full Text] [Related]
12. Comparison of forearm versus upper arm basilic transposition arteriovenous fistulas demonstrates equivalent satisfactory patency.
Weaver ML; Holscher CM; Sorber R; Arnold MW; Lum YW; Reifsnyder T
J Vasc Surg; 2019 Oct; 70(4):1247-1252. PubMed ID: 31147119
[TBL] [Abstract][Full Text] [Related]
13. Association between heart failure and arteriovenous access patency in patients with end-stage renal disease on hemodialysis.
Fisher AT; Mulaney-Topkar B; Sheehan BM; Garcia-Toca M; Sorial E; Sgroi MD
J Vasc Surg; 2024 May; 79(5):1187-1194. PubMed ID: 38157996
[TBL] [Abstract][Full Text] [Related]
14. Snuffbox arteriovenous fistulas have similar outcomes and patency as wrist arteriovenous fistulas.
Siracuse JJ; Cheng TW; Arinze NV; Levin SR; Jones DW; Malas MB; Kalish JA; Rybin D; Farber A
J Vasc Surg; 2019 Aug; 70(2):554-561. PubMed ID: 30837175
[TBL] [Abstract][Full Text] [Related]
15. Association of Anesthesia Type with Outcomes after Outpatient Brachiocephalic Arteriovenous Fistula Creation.
Levin SR; Farber A; Malas MB; Tan TW; Conley CM; Salavati S; Arinze N; Cheng TW; Rybin D; Siracuse JJ
Ann Vasc Surg; 2020 Oct; 68():67-75. PubMed ID: 32504791
[TBL] [Abstract][Full Text] [Related]
16. Single-stage basilic vein transposition-An effective and viable autogenous access for dialysis.
Basavanthappa R; Luthra L; Gangadharan AN; A RK; M AK; Jp VV; Ar C; Desai SC
Vascular; 2020 Dec; 28(6):760-764. PubMed ID: 32389064
[TBL] [Abstract][Full Text] [Related]
17. Upper limb grafts for hemodialysis access.
Shemesh D; Goldin I; Verstandig A; Berelowitz D; Zaghal I; Olsha O
J Vasc Access; 2015; 16 Suppl 9():S34-9. PubMed ID: 25751548
[TBL] [Abstract][Full Text] [Related]
18. Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative.
Tan TW; Siracuse JJ; Brooke BS; Baril DT; Woo K; Rybin D; Doros G; Farber A
J Vasc Surg; 2019 Apr; 69(4):1187-1195.e2. PubMed ID: 30301685
[TBL] [Abstract][Full Text] [Related]
19. A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population.
Stoumpos S; Traynor JP; Metcalfe W; Kasthuri R; Stevenson K; Mark PB; Kingsmore DB; Thomson PC
J Vasc Surg; 2019 Jun; 69(6):1889-1898. PubMed ID: 30583903
[TBL] [Abstract][Full Text] [Related]
20. Revision of Aneurysmal Arteriovenous Access with Immediate Use Graft Is Safe and Avoids Prolonged Use of Tunneled Hemodialysis Catheters.
Naazie IN; Janssen C; Perez S; Mathlouthi A; Cajas-Monson L; Malas M; Al-Nouri O
Ann Vasc Surg; 2022 Nov; 87():295-301. PubMed ID: 36162627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
